Tamoxifen Treatment for Breast Cancer and Risk of Endometrial Cancer: A Case-Control Study
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/97/5/375/7774979/dji057.pdf
Reference30 articles.
1. Tamoxifen Therapy for Breast Cancer and Endometrial Cancer Risk
2. Risk of endometrial cancer after tamoxifen treatment of breast cancer
3. Population-Based Study of Tamoxifen Therapy and Subsequent Ovarian, Endometrial, and Breast Cancers
4. Potential Role of Tamoxifen in Prevention of Breast Cancer
5. Tamoxifen for the Primary Prevention of Breast Cancer: A Review and Critique of the Concept and Trial
Cited by 174 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An Unusual Occurrence of Tamoxifen-Induced Maculopathy in a Young Woman With Hormone Receptor-Positive Post-mastectomy Breast Carcinoma;Cureus;2024-07-14
2. Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study;The Lancet Regional Health - Europe;2024-05
3. Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?;Drugs;2024-03-14
4. Endometrial Cancer;Biomedical Aspects of Solid Cancers;2024
5. Risks of Second Primary Cancers for Female and Male Breast Cancer Survivors in England: A Retrospective Cohort Study;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3